GALASSO, Marco
 Distribuzione geografica
Continente #
NA - Nord America 2.219
EU - Europa 639
AS - Asia 242
SA - Sud America 1
Totale 3.101
Nazione #
US - Stati Uniti d'America 2.218
PL - Polonia 218
CN - Cina 167
IT - Italia 123
UA - Ucraina 88
DE - Germania 73
TR - Turchia 53
GB - Regno Unito 51
SE - Svezia 28
FI - Finlandia 19
BE - Belgio 15
RU - Federazione Russa 15
VN - Vietnam 14
IN - India 3
CZ - Repubblica Ceca 2
FR - Francia 2
HK - Hong Kong 2
NL - Olanda 2
CA - Canada 1
CL - Cile 1
IR - Iran 1
KR - Corea 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
PT - Portogallo 1
Totale 3.101
Città #
Fairfield 396
Woodbridge 298
Warsaw 218
Ashburn 187
Houston 173
Chandler 163
Ann Arbor 129
Seattle 129
Wilmington 124
Cambridge 123
Jacksonville 106
Ferrara 61
Beijing 39
Izmir 39
Addison 33
Nanjing 33
Princeton 31
Milan 30
Shanghai 27
Dearborn 26
San Diego 23
Bremen 22
New York 18
Boardman 17
Brussels 15
Dong Ket 13
Nanchang 11
London 8
Shenyang 8
Changsha 6
Jinan 6
Orange 6
Auburn Hills 5
Jiaxing 5
Mountain View 5
Tianjin 5
Augusta 4
Cagliari 4
Casalecchio Di Reno 4
Des Moines 4
Falls Church 4
Hebei 4
Hefei 4
Leawood 4
San Mateo 4
Zhengzhou 4
Chicago 3
Kunming 3
Lanzhou 3
Los Angeles 3
Norwalk 3
Redwood City 3
Alghero 2
Hong Kong 2
Indiana 2
Islington 2
Massa Fiscaglia 2
Monmouth Junction 2
Mumbai 2
Prescot 2
Redmond 2
Amsterdam 1
Andover 1
Ardabil 1
Barsinghausen 1
Benevento 1
Brno 1
Changchun 1
Chisinau 1
Chiswick 1
Cupertino 1
Edinburgh 1
Gualtieri 1
Guangzhou 1
Haikou 1
Helsinki 1
Ho Chi Minh City 1
Imola 1
Kuala Lumpur 1
Ningbo 1
Potenza 1
Rossano Veneto 1
San Cipriano Picentino 1
Southwark 1
Suwon 1
Taiyuan 1
Toronto 1
Walnut 1
Wuhan 1
Yellow Springs 1
Totale 2.643
Nome #
A systems biology approach to non-coding RNAs: the networks of cancer 180
Loss of miR-204 expression is a key event in melanoma 161
MicroRNA Expression Signatures in Solid Malignancies 160
miRNA signatures associate with pathogenesis and progression of osteosarcoma. 153
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. 147
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells 147
Identification of microRNA activity by Targets' Reverse EXpression. 145
Association between idiopathic hearing loss and mitochondrial DNA mutations: a study on 169 hearing-impaired subjects 140
Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. 138
Prion proteins (PRNP and PRND) are over-expressed in osteosarcoma 133
null 132
null 119
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors 119
Risk factors associated with relapse of eyelid basal cell carcinoma: results from a retrospective study of 142 patients 118
GAMES identifies and annotates mutations in next-generation sequencing projects 116
Reprogramming of miRNA networks in cancer and leukemia 109
A miRNA signature for defining aggressive phenotype and prognosis in gliomas 99
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 98
null 87
A long non-coding RNA inside the type 2 transglutaminase gene tightly correlates with the expression of its transcriptional variants 83
null 80
miR-130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology 74
Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts 68
Profiling of the Predicted Circular RNAs in Ductal In Situ and Invasive Breast Cancer: A Pilot Study 68
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis 64
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells 64
MiR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model 59
Deregulated microRNAs in breast ductal carcinoma in situ (DCIS) with invasive propensity 31
Next generation analysis of breast cancer genomes for precision medicine. 24
A large scale expression study associates uc.283-plus lncRNA with pluripotent stem cells and human glioma 19
Non-coding RNAs: a key to future personalized molecular therapy? 16
Pluripotent stem cell miRNAs and metastasis in invasive breast cancer. 10
Blood to skin recirculation of CD4+ memory T cells associates with cutaneous and systemic manifestations of psoriatic disease 9
Totale 3.170
Categoria #
all - tutte 10.053
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.053


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019412 0 0 0 0 0 0 0 0 43 83 125 161
2019/2020857 97 35 35 128 70 104 90 83 81 80 25 29
2020/2021616 37 51 32 52 66 63 34 66 29 81 66 39
2021/2022325 29 41 20 6 15 17 19 7 10 41 27 93
2022/2023365 30 15 21 49 65 49 32 31 43 8 16 6
2023/2024133 22 21 5 5 5 29 21 19 6 0 0 0
Totale 3.170